Jeong Kyong Ju, Kim Go Woon, Chung Sung Hyun
Department of Pharmacology and Clinical Pharmacy, College of Pharmacy, Kyung Hee University, Seoul, Korea.
J Ginseng Res. 2014 Apr;38(2):83-8. doi: 10.1016/j.jgr.2013.11.014. Epub 2013 Dec 18.
The adenosine monophosphate (AMP)-activated protein kinase (AMPK) is a key sensor of cellular energy. Once activated, it switches on catabolic pathways generating adenosine triphosphate (ATP), while switching off biosynthetic pathways consuming ATP. Pharmacological activation of AMPK by metformin holds a therapeutic potential to reverse metabolic abnormalities such as type 2 diabetes and nonalcoholic fatty liver disease. In addition, altered metabolism of tumor cells is widely recognized and AMPK is a potential target for cancer prevention and/or treatment. Panax ginseng is known to be useful for treatment and/or prevention of cancer and metabolic diseases including diabetes, hyperlipidemia, and obesity. In this review, we discuss the ginseng extracts and ginsenosides that activate AMPK, we clarify the various mechanisms by which they achieve this, and we discuss the evidence that shows that ginseng or ginsenosides might be useful in the treatment and/or prevention of metabolic diseases and cancer.
腺苷单磷酸(AMP)激活的蛋白激酶(AMPK)是细胞能量的关键传感器。一旦被激活,它会开启产生三磷酸腺苷(ATP)的分解代谢途径,同时关闭消耗ATP的生物合成途径。二甲双胍对AMPK的药理激活具有逆转2型糖尿病和非酒精性脂肪性肝病等代谢异常的治疗潜力。此外,肿瘤细胞代谢改变已得到广泛认可,AMPK是癌症预防和/或治疗的潜在靶点。人参已知可用于治疗和/或预防癌症以及包括糖尿病、高脂血症和肥胖症在内的代谢性疾病。在本综述中,我们讨论了激活AMPK的人参提取物和人参皂苷,阐明了它们实现这一作用的各种机制,并讨论了表明人参或人参皂苷可能对治疗和/或预防代谢性疾病及癌症有用的证据。